CentreStone Ventures is a life sciences focused venture capital fund investing primarily in companies developing early stage therapeutics, medical devices, diagnostics and new drug delivery methods.
Companies that interest CentreStone develop products for large markets with unmet clinical needs. They have technologies based on solid intellectual property, a combination of entrepreneurial and technical expertise, and the potential to become leaders in their respective markets. CentreStone prefers to focus on seed and early stage investments, but also maintains a diverse life science portfolio with companies at varying stages of development.
Companies in the fund’s portfolio are selected after a rigorous due diligence process that evaluates opportunities based on CentreStone’s knowledge of market conditions, industry comparables and the overall competitive landscape.
In addition to providing capital, CentreStone works closely with its portfolio companies providing the structure, support and guidance required to establish a strong foundation for commercial development.
For more information, please contact:
Rick Pauls, Managing Director rpauls@centrestoneventures.com
(204) 477-7590
Suite 7- 1250 Waverley Street, Winnipeg, MB, Canada, R3T 6C6
This page made possible by LSAM's exclusive sector directory sponsor.
